On the basis of this report, we hypothesized that IKKα-mediated DARPP-32 phosphorylation inhibits PP1α activity in NSCLC cells and promotes oncogenic growth by activating cell signaling pathways. The gene discussed is PPP1R1B; the disease is non-small cell lung carcinoma.